Figure 1: Comparing patient importance of composite endpoint components across trials

Qualitative assessment of component importance across selected trials. Importance ratings reflect patient experience and clinical severity. Sources: DAPA-HF: N Engl J Med 2019;381:1995-2008; TRITON-TIMI 38: N Engl J Med 2007;357:2001-2015; EMPA-KIDNEY: N Engl J Med. 2023;388:117-127.
Chart: Letters from a PharmacistGet the dataCreated with Datawrapper